Gland Pharma Limited, a leading Indian pure-play generic injectable pharmaceutical products company, announced the signing of a definitive agreement under which Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (together with its subsidiaries), a leading Chinese health care provider (stock code: 600196.SH,02196.HK), will acquire an approximate 86 percent stake in Gland for up to US$1.26 billion. Based…
Study: 9 in 10 Life Science Organizations Worry About Drug Pricing Pressures
The drug pricing debate continues to plague the life sciences sector, fueled by public criticism of rising costs and calls for regulatory change in the midst of the election season. Nearly nine in ten (89 percent) life sciences organizations identify drug pricing pressures as a considerable risk, according to a new report from BDO USA, LLP, a leading accounting…
GHO Capital Announces Acquisition of Caprion Biosciences
GHO Capital, the European specialist investor in healthcare, announced the acquisition of Caprion Biosciences, Inc., the leading provider of proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Caprion is a specialist laboratory services company which provides testing services to pharmaceutical and biotechnology companies for research and development activities. The company provides two types…
WHO Prequalifies Prevenar 13 For Multi-Dose Vial Presentation
NEW YORK–(BUSINESS WIRE) — Pfizer Inc. has announced that the World Health Organization (WHO) has prequalified its four-dose, multi-dose vial (MDV) presentation of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13 – valent, adsorbed]). WHO prequalification allows for the global use of Prevenar 13 MDV by United Nations agencies and countries worldwide that require WHO prequalification.…
FDA Approves Genentech’s Xolair For Allergic Asthma In Children
SOUTH SAN FRANCISCO, Calif. — Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) to treat moderate to severe persistent asthma in children six to 11 years of age, who have had a positive skin test or in vitro reactivity to an airborne allergen and have symptoms that are…
Investigation of INSYS Therapeutics Inc.
Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm, has commenced an investigation into possible violations of the federal securities laws by certain officers and directors at INSYS Therapeutics, Inc. Insys is a specialty pharmaceutical company that develops and commercializes supportive care products primarily designed to assist patients with pain management. Insys’ core product and source of revenue…
BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer
Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals
Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant Pharmaceuticals, a private, Stockholm, Sweden-based pharmaceutical company focused on the development of therapies for cancer and rare diseases. The acquisition gives Bristol-Myers Squibb full rights to Cormorant’s HuMax-IL8 antibody program and the lead candidate HuMax-IL8, a Phase 1/2 monoclonal antibody targeted against interleukin-8 (IL-8)…
ICON to Acquire Clinical Research Management, Inc.
ICON plc has agreed, subject to certain customary closing conditions (including applicable regulatory approvals), to acquire Clinical Research Management, Inc. (ClinicalRM). The acquisition will enhance ICON’s ability to access the market for government sponsored research and further enhances ICON’s capabilities in the areas of Vaccines and Infectious Disease. ClinicalRM provide full service and functional research…
GE Healthcare Opens Life Sciences North American Headquarters
GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, today opened its new 210,000 square-foot North American headquarters in Marlborough, Massachusetts. At full capacity in 2017, it will employ more than 500 scientists and professionals in the Boston area focused on accelerating precision medicine across…